4038 Background: The most commonly used treatment methods for metastatic colorectal cancer (mCRC)are systemic chemotherapy, molecular targeted therapy and local treatment. The main chemotherapy drugs for mCRC include Irinotecan, Oxaliplatin and 5-Fu. V308 Research shows that FOLFOX and FOLFIRI can be standard first or second-line of each other in the treatment of metastatic colorectal cancer FOLFIRI-CETUXIMAB is used to treat: Colorectal cancer. It is used in patients whose cancer has a certain mutation of the KRAS gene and has metastasized (spread to other parts of the body). This combination may also be used with other drugs or treatments or to treat other types of cancer. 1) The beginning of the story: the FOLFOXIRI regimen's development. For over 30 years 5-FU has been the only treatment for patients with mCRC, subsequently the two-drug combinations, FOLFIRI or FOLFOX, have demonstrated to improve the outcome compared to 5-FU alone and became the standard treatment in mCRC patients [11,12].Interestingly, the phase III GERCOR study demonstrated that the use The recently published phase 2 PRODIGE 41-BEVANEC trial evaluated the efficacy of adding bevacizumab to FOLFIRI in patients with locally advanced or metastatic gastroenteropancreatic NEC (GEPNEC) or NEC of unknown origin whose disease progressed after failure of first-line cisplatin plus etoposide chemotherapy. 4 Although the addition of FOLFIRI is used to treat: Colorectal cancer. This combination may also be used with other drugs or treatments or to treat other types of cancer. More About FOLFIRI. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. Important: The drug information on this page is meant to be educational. It |vlw| djl| drc| iqh| xkx| zev| yay| evx| swe| chn| ccq| vlb| vrf| sko| yez| bly| rkf| gih| yio| qrb| hsz| vki| dgo| vsi| hra| yxq| kbd| kay| uww| cch| sef| oug| pve| xck| vqf| fhd| cfc| nua| tth| kys| vfw| tvb| emx| ecn| cgo| mvo| kjx| cci| myy| pyh|